Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CDRH Premarket Division Reviews Mulled By ODE Incoming Director Schultz

This article was originally published in The Gray Sheet

Executive Summary

Incoming Office of Device Evaluation Director Daniel Schultz, MD, is considering quality reviews of CDRH's premarket programs in 2003
Advertisement

Related Content

Device Center Seeks Outside Expertise Through University Partnerships
ODE Division Director Ulatowski Appointed Office Of Compliance Chief
CDRH’s Marlowe To Coordinate FDA Science Standards; Kessler Will Head OST
CDRH Logs 226 More 510(k)s In FY 2002; Review Times Slip Four Days
CDRH In Transition? Premarket, Compliance Directorships In Flux
CDRH In Transition? Premarket, Compliance Directorships In Flux
CDRH Looks Outside Its Walls To Augment Scientific Expertise
FDA Reform Bill Introduced Dec. 20 By Reps. Greenwood, Eshoo
FDA compliance
Third-Party Device Pilot Final Guidance Has Fewer Strings Attached
Advertisement
UsernamePublicRestriction

Register

MT017016

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel